ChandrasenaNPremaratnaRGunaratnaIEde SilvaNR.Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: current status and future prospects. PLOS Negl Trop Dis. 2018;12(5):e6472. doi:10.1371/journal.pntd.0006472
2.
CanteyPTRoutJRaoGWilliamsonJFoxLAM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. Plos Negl Trop Dis. 2010;4(6):728. doi:10.1371/journal.pntd.0000728
3.
TaylorMThomasROliverSGarnerP.Community views on mass drug administration for filariasis: a qualitative evidence synthesis. Cochrane Database System Rev. 2022;2022(2):CD013638. doi:10.1002/14651858.CD013638.pub2
4.
KvarnströmKWesterholmAAiraksinenMLiiraH.Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative Research. Pharmaceutics. 2021;13(7):1100. doi:10.3390/pharmaceutics13071100
5.
NilesRAThickstunCRCoxH, et al. Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana. PLOS Negl Trop Dis. 2021;15(9):e0009596.
6.
UddinMFMolyneuxSMurayaK, et al. Gender-related influences on adherence to advice and treatment-seeking guidance for infants and young children post-hospital discharge in Bangladesh. Int J Equity Health. 2021;20(1):64.
7.
AmarilloMLEBelizariaVYSadiang-AbayJT, et al. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines. Parasites Vectors. 2008;1:14.
8.
KrentelAFischerPUWeilGJ.A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. Plos Negl Trop Dis. 2013;7(11):e2447. doi:10.1371/journal.pntd.0002447
9.
OffeiMAntoF.Compliance to mass drug administration programme for Lymphatic Filariasis elimination by community members and volunteers in the Ahanta West District of Ghana. J Bacteriol Parasitol. 2014;5:180: doi:10.4172/2155-9597.1000180
10.
World Health Organization. WHO Informal Consultation on Fever Management in Peripheral Health Care Settings: A Global Review of Evidence and Practice. Geneva, Switzerland: WHO Press; 2013.